RaySearch Laboratories AB (publ) (ST:RAY-B) — Stock Price
RaySearch Laboratories AB (publ) (ST:RAY-B) is currently trading at Skr187.70 SEK, up 4.34% today. Over the past 52 weeks, shares have ranged between Skr164.40 and Skr282.50. This page tracks RaySearch Laboratories AB (publ)'s live share price on the ST exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see RAY-B market cap overview.
RaySearch Laboratories AB (publ) (RAY-B) Stock Price Chart — Daily History & Trading Volume
The chart below tracks RaySearch Laboratories AB (publ)'s daily closing share price and trading volume on the ST exchange over the past year, giving a clear view of recent price momentum and liquidity.
RaySearch Laboratories AB (publ) Income Statement — Revenue, Profit & Earnings by Year
RaySearch Laboratories AB (publ)'s annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | Skr1.34 Billion | Skr1.19 Billion | Skr1.02 Billion | Skr843.65 Million | Skr641.67 Million |
| Cost of Revenue | Skr392.90 Million | Skr99.49 Million | Skr106.58 Million | Skr94.99 Million | Skr50.40 Million |
| Gross Profit | Skr951.40 Million | Skr1.09 Billion | Skr915.58 Million | Skr748.66 Million | Skr591.28 Million |
| Research & Development | Skr270.40 Million | Skr269.38 Million | Skr237.74 Million | Skr238.77 Million | Skr233.44 Million |
| SG&A | Skr650.20 Million | Skr249.59 Million | Skr195.16 Million | Skr171.72 Million | Skr122.04 Million |
| Total Operating Expenses | Skr629.60 Million | Skr832.04 Million | Skr800.70 Million | Skr718.35 Million | Skr655.32 Million |
| Operating Income | Skr321.80 Million | Skr260.49 Million | Skr114.88 Million | Skr42.74 Million | Skr-52.64 Million |
| EBITDA | Skr612.80 Million | Skr571.28 Million | Skr405.94 Million | Skr340.85 Million | Skr197.36 Million |
| EBIT | Skr321.80 Million | Skr271.91 Million | Skr119.78 Million | Skr43.85 Million | Skr-52.64 Million |
| Interest Expense | Skr4.50 Million | Skr9.05 Million | Skr9.69 Million | Skr11.48 Million | Skr6.04 Million |
| Income Before Tax | Skr287.80 Million | Skr262.87 Million | Skr110.09 Million | Skr32.38 Million | Skr-58.67 Million |
| Income Tax Expense | Skr60.00 Million | Skr59.35 Million | Skr28.52 Million | Skr8.60 Million | Skr-11.36 Million |
| Net Income | Skr227.80 Million | Skr203.51 Million | Skr81.57 Million | Skr23.78 Million | Skr-47.31 Million |
RaySearch Laboratories AB (publ) Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes RaySearch Laboratories AB (publ)'s financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | Skr1.99 Billion | Skr2.09 Billion | Skr1.95 Billion | Skr1.88 Billion | Skr1.74 Billion |
| Total Current Assets | Skr970.70 Million | Skr984.75 Million | Skr802.45 Million | Skr627.92 Million | Skr516.37 Million |
| Cash & Equivalents | Skr407.30 Million | Skr462.74 Million | Skr343.68 Million | Skr160.27 Million | Skr102.53 Million |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | Skr541.40 Million | Skr468.13 Million | Skr401.79 Million | Skr398.26 Million | Skr397.44 Million |
| Inventory | Skr22.00 Million | Skr10.62 Million | Skr9.32 Million | Skr14.09 Million | Skr29.99 Million |
| Property, Plant & Equipment | Skr447.30 Million | Skr526.66 Million | Skr590.42 Million | Skr649.07 Million | Skr666.82 Million |
| Goodwill | — | — | — | — | — |
| Total Liabilities | Skr1.01 Billion | Skr1.21 Billion | Skr1.22 Billion | Skr1.22 Billion | Skr1.09 Billion |
| Total Current Liabilities | Skr569.90 Million | Skr703.82 Million | Skr675.05 Million | Skr614.10 Million | Skr490.08 Million |
| Long-term Debt | — | — | — | Skr497.82 Million | Skr491.90 Million |
| Net Debt | Skr-12.50 Million | Skr9.19 Million | Skr185.68 Million | Skr395.12 Million | Skr458.86 Million |
| Total Stockholder Equity | Skr985.30 Million | Skr876.71 Million | Skr735.23 Million | Skr657.16 Million | Skr649.28 Million |
| Retained Earnings | Skr982.00 Million | Skr856.93 Million | Skr721.98 Million | Skr640.41 Million | Skr637.60 Million |
RaySearch Laboratories AB (publ) Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how RaySearch Laboratories AB (publ) generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | Skr387.00 Million | Skr485.23 Million | Skr455.93 Million | Skr356.78 Million | Skr238.16 Million |
| Capital Expenditures | Skr28.10 Million | Skr217.54 Million | Skr209.33 Million | Skr231.50 Million | Skr255.22 Million |
| Free Cash Flow | Skr358.90 Million | Skr267.69 Million | Skr246.60 Million | Skr125.28 Million | Skr-17.06 Million |
| Investing Cash Flow | Skr-228.10 Million | Skr-217.54 Million | Skr-209.33 Million | Skr-231.50 Million | Skr-237.63 Million |
| Financing Cash Flow | Skr-179.60 Million | Skr-159.78 Million | Skr-56.35 Million | Skr-72.49 Million | Skr-72.23 Million |
| Dividends Paid | Skr102.80 Million | Skr68.57 Million | — | — | — |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | Skr291.00 Million | Skr299.37 Million | Skr286.15 Million | Skr296.99 Million | Skr250.00 Million |
| Change in Cash | Skr-55.44 Million | Skr119.06 Million | Skr183.41 Million | Skr57.73 Million | Skr-66.21 Million |
RaySearch Laboratories AB (publ) Earnings History — EPS Actual vs. Analyst Estimates
Track RaySearch Laboratories AB (publ)'s quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Aug 13, 2026 | — | 1.88 | — |
| May 07, 2026 | 1.55 | — | — |
| Feb 12, 2026 | 2.00 | 1.63 | +22.70% |
| Nov 07, 2025 | 2.09 | 1.47 | +42.18% |
| Aug 08, 2025 | 0.90 | 1.00 | -10.00% |
| May 09, 2025 | 1.66 | 1.45 | +14.48% |
| Feb 21, 2025 | 1.75 | 1.32 | +32.58% |
| Nov 08, 2024 | 1.32 | 0.65 | +103.08% |